The Ozempic maker is partnering with the AI firm to speed up drug development.

Sept 16 (Reuters) - Novo Nordisk has partnered with Anthropic to use the AI giant's Claude models to speed up discovery and ...

Novo said it will initially test Claude Science for specific workflows in R&D and address scientific problems where the collaboration would have the biggest impact. Novo will also use Anthropic's ...

The Danish pharmaceutical company is best known for the weight-loss drug Wegovy. Its latest partnership aims to find the next ...

Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science ...

Novo Nordisk is partnering with Anthropic to use artificial intelligence to accelerate the discovery and development of new ...

The Danish drugmaker will use Claude Science as part of a goal to become "the world’s most AI-driven healthcare company." ...

Novo has added Anthropic's Claude to its drug discovery toolkit, shortly after the tech firm revealed a new AI workbench for ...

Novo Nordisk and Anthropic will co-develop AI solutions for defined discovery bottlenecks, focusing on biological reasoning, scientific workflows, and accelerating progression from research insights ...

Novo Nordisk and Anthropic announced a collaboration to deploy Claude Science and other frontier AI models to speed up drug ...

Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them ...

Healthcare giant Novo Nordisk announced a partnership Wednesday with artificial intelligence company Anthropic to help discover and develop new medicines faster. Under the agreement, Novo will tap ...